bovin
viral
diarrhea
viru
bvdv
infect
caus
signific
econom
loss
cattl
industri
worldwid
still
repres
huge
pressur
agricultur
product
thu
develop
novel
antibvdv
strategi
urgent
need
nonstructur
protein
bvdv
essenti
viral
replic
camel
singledomain
antibodi
nanobodi
repres
promis
antivir
approach
advantag
small
size
stabl
structur
high
specif
solubl
recognit
specif
epitop
howev
nanobodi
bvdv
report
studi
nanobodi
isol
phage
display
librari
variabl
domain
camellida
heavi
chainonli
antibodi
vhh
mdbk
cell
line
stabli
express
establish
explor
antivir
activ
result
show
could
markedli
suppress
bvdv
replic
interact
bvdv
protein
suggest
nanobodi
potenti
develop
novel
antivir
drug
bvdv
infect
bovin
viral
diarrhea
bvd
caus
bvd
viru
bvdv
infect
one
import
viral
diseas
cattl
caus
enorm
econom
loss
livestock
industri
worldwid
suda
et
al
time
also
one
main
pollut
cattlederiv
biolog
product
yarnal
thrusfield
due
complex
diseas
pathogenesi
effect
mean
control
treat
bvdv
infect
quinet
et
al
therefor
imper
develop
effici
antivir
strategi
combat
bvdv
infect
cattl
industri
bvdv
positivestrand
rna
viru
belong
pestiviru
genu
flavivirida
famili
rna
genom
bvdv
approxim
kb
consist
singl
larg
open
read
frame
utr
end
encod
polymer
protein
process
host
viral
proteas
capsid
protein
three
envelop
glycoprotein
e
rn
e
e
seven
eight
nonstructur
protein
nsp
compris
n
pro
collett
et
al
tautz
et
al
first
four
protein
structur
wherea
rest
nonstructur
function
viral
assembl
replic
host
immun
evas
locat
carboxyl
terminu
polyprotein
highli
conserv
among
pestivirus
confirm
possess
rnadepend
rna
polymeras
rdrp
activ
respons
transcript
replic
viral
genom
zhong
et
al
due
uniqu
characterist
ideal
target
develop
antivir
drug
bvdv
singledomain
antibodi
also
known
nanobodi
nb
deriv
heavi
chain
antibodi
variabl
region
vhh
camelid
consid
smallest
avail
intact
antigenbind
fragment
hamerscasterman
et
al
muylderman
et
al
nanobodi
desir
properti
small
volum
kda
good
antigen
bind
perform
strong
tissu
penetr
high
stabil
zou
et
al
attract
featur
make
benefici
immunoassay
therapeut
applic
addit
major
nanobodi
intrins
stabil
suffici
proper
fold
intracellular
function
rothbauer
et
al
exampl
trival
nanobodi
bind
fusion
protein
surfac
rsv
therebi
inhibit
viral
replic
novel
inhal
biotherapeut
develop
treatment
rsv
infect
infant
current
clinic
phase
iii
trial
detal
et
al
lario
mora
et
al
addit
nanobodi
drug
clinic
applic
studi
refer
antivir
effect
specif
nanobodi
vitro
nanobodi
found
effect
block
duck
hav
replic
target
conserv
b
cell
epitop
viru
xue
et
al
anoth
nanobodi
target
merscov
receptorbind
region
significantli
abrog
viru
replic
via
neutral
activ
zhao
et
al
intracellularlyexpress
found
potent
suppress
porcin
reproduct
respiratori
syndrom
replic
liu
et
al
nevertheless
report
use
nanobodi
antivir
therapi
bvdv
date
studi
bactrian
camel
immun
solubl
recombin
protein
vhh
librari
construct
eight
specif
nanobodi
isol
phage
display
mdbk
cell
line
stabli
express
nanobodi
establish
use
lentivir
packag
technolog
vitro
result
indic
one
nanobodi
could
strongli
suppress
bvdv
replic
first
report
antibvdv
nanobodi
could
lead
develop
novel
antibvdv
strategi
anim
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
northwest
agricultur
forestri
univers
nwafu
anim
protocol
approv
iacuc
nwafu
cell
madin
darbi
bovin
kidney
mdbk
cell
purchas
china
center
type
cultur
collect
cctcc
beij
china
maintain
dulbecco
modifi
eagl
medium
dmem
life
technolog
corpor
new
york
ca
usa
supplement
fetal
bovin
serum
fb
antibioticantimycot
life
technolog
corpor
shanghai
china
co
atmospher
bvdv
strain
oregon
v
cvcc
obtain
cctcc
propag
mdbk
cell
briefli
describ
follow
mdbk
cell
flask
inocul
moi
bvdv
ml
dmem
cell
reach
confluenc
incub
h
medium
replac
fresh
fb
dmem
cell
cultur
h
abund
visibl
cytopath
effect
cpe
observ
cell
supernat
harvest
freezethaw
three
time
follow
centrifug
g
min
supernat
harvest
aliquot
ml
ep
tube
virus
titrat
mdbk
cell
store
use
gene
encod
segment
amplifi
pcr
bvdv
cdna
clone
prokaryot
express
vector
novagen
darmstadt
germani
creat
recombin
plasmid
primer
use
pcr
amplif
list
supplement
tabl
plasmid
transform
e
coli
transetta
transgen
biotech
beij
china
cell
express
protein
induct
mm
iptg
h
bacteria
collect
centrifug
follow
resuspens
buffer
mm
tri
ph
mm
nacl
mm
imidazol
mm
dtt
sonic
centrifug
clear
cell
lysat
load
onto
ninta
column
qiagen
hilden
germani
elut
use
imidazol
mm
follow
load
onto
superdex
gel
filtrat
column
ge
healthcar
life
scienc
pittsburgh
usa
peak
fraction
contain
recombin
protein
pool
analyz
sdspage
western
blot
year
old
male
alashan
bactrian
camel
immun
subcutan
day
mg
solubl
recombin
protein
combin
freund
complet
adjuv
accord
previou
report
vinck
et
al
serum
antibodi
titer
last
immun
evalu
via
indirect
enzymelink
immunosorb
assay
ielisa
describ
briefli
follow
micropl
coat
recombin
protein
ng
well
incub
serial
dilut
camel
serum
follow
incub
mous
anticamel
antiserum
prepar
lab
secondari
antibodi
hrpconjug
goat
antimous
igg
jackson
immunoresearch
laboratori
west
grove
pa
usa
third
antibodi
serum
antibodi
titer
calcul
use
graphpad
prism
last
immun
peripher
blood
mononuclear
cell
pbmc
isol
ml
blood
sampl
use
tube
greiner
bioon
frickenhausen
germani
total
rna
extract
cdna
synthes
revers
transcriptionpcr
rtpcr
use
transscript
cdna
synthesi
supermix
transgen
biotech
china
subsequ
vhh
gene
amplifi
nest
pcr
bp
ligat
phagemid
vector
pcantab
ge
healthcar
life
scienc
pittsburgh
usa
construct
bimod
camel
heavi
chain
antibodi
variabl
region
librari
biopan
perform
previous
describ
vinck
et
al
follow
modif
nanobodi
screen
three
round
pan
use
phage
display
technolog
enrich
specif
phage
particl
monitor
use
conjug
elisa
togeth
phage
titrat
coloni
pick
randomli
induc
mm
iptg
express
solubl
vhh
etag
recombin
vhhsetag
protein
extract
periplasm
test
capac
bind
protein
use
ielisa
antietag
antibodi
genscript
piscataway
nj
usa
final
posit
clone
identifi
sequenc
nanobodi
group
accord
sequenc
addit
nanobodi
better
affin
select
subsequ
experi
vhh
gene
amplifi
primer
nbf
nbr
use
pcantab
plasmid
templat
insert
ptripcmvpuro
vector
prepar
laboratori
xbai
bamhi
restrict
site
construct
ptripcmvnb
egfp
puro
recombin
plasmid
sequenc
primer
list
supplementari
tabl
produc
pseudotyp
lentiviru
particl
cell
plate
cotransfect
ptripcmvnb
egfp
puro
g
plasmid
use
xtremegen
hp
dna
transfect
reagent
roch
life
scienc
usa
accord
manufactur
instruct
subsequ
h
post
transfect
green
fluoresc
reach
approxim
observ
fluoresc
microscop
cell
cultur
supernat
collect
cell
debri
remov
brief
centrifug
rpm
min
clear
supernat
store
use
mdbk
cell
transduc
pseudotyp
lentivirus
express
nanobodi
supplement
polybren
sigma
st
loui
mo
usa
h
later
transduc
cell
screen
ad
puromycin
thermo
fisher
scientif
shanghai
china
surviv
cell
monitor
use
fluoresc
microscopi
express
nanobodyegfp
fusion
protein
analyz
western
blot
mdbk
cell
line
stabli
express
nanobodyegfp
h
duan
et
al
veterinari
microbiolog
fusion
protein
design
mdbknb
egfp
viabil
mdbknb
egfp
cell
line
evalu
use
cell
count
assay
beyotim
nanj
china
previous
describ
xiao
et
al
briefli
mdbk
mdbknb
egfp
cell
line
ad
well
plate
well
cultur
co
cell
collect
count
digest
trypsin
assess
three
well
per
cell
per
day
cell
prolifer
curv
plot
statist
one
week
data
western
blot
perform
previous
describ
zhang
et
al
minor
modif
cell
harvest
lyse
use
lysi
buffer
beyotim
shanghai
china
supplement
proteas
inhibitor
phenylmethanesulfonyl
fluorid
pmsf
protein
concentr
determin
use
bicinchonin
acid
protein
assay
kit
thermo
fisher
scientif
shanghai
china
total
protein
subject
sdspage
transfer
pvdf
membran
millipor
billerica
usa
cellular
protein
probe
one
follow
primari
antibodi
mous
antibvdv
polyclon
antibodi
dilut
produc
laboratori
see
supplementari
mous
antigfp
monoclon
antibodi
tiangen
beij
china
dilut
antibodi
abcam
cambridg
uk
dilut
follow
incub
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
dilut
jackson
west
grove
pa
usa
secondari
antibodi
immunolabel
protein
visual
use
ecl
chemiluminesc
detect
system
accord
manufactur
instruct
pierc
rockford
il
usa
total
rna
extract
cell
supernat
use
trizol
reagent
invitrogen
carlsbad
ca
usa
measur
concentr
ng
total
rna
revers
transcrib
cdna
use
primescript
rt
reagent
kit
takara
dalian
china
accord
manufactur
instruct
rtqpcr
conduct
use
stepon
plu
realtim
pcr
system
appli
biosystem
foster
citi
ca
usa
faststart
univers
sybr
green
master
roch
basl
switzerland
reaction
perform
volum
reaction
condit
follow
min
cycl
mrna
determin
simultan
intern
control
method
use
calcul
rel
gene
express
level
primer
use
rtqpcr
amplif
list
supplement
tabl
evalu
bvdv
rna
copi
cultur
supernat
plasmid
contain
bp
fragment
bvdv
util
gener
standard
curv
plot
result
parallel
pcr
perform
serial
dilut
standard
plasmid
absolut
quantiti
supernat
rna
copi
calcul
accord
standard
curv
viru
titrat
detect
perform
describ
previous
xiao
et
al
briefli
mdbk
cell
trypsin
plate
cell
cultur
plate
densiti
cellswel
h
infect
bvdv
sampl
supernat
serial
dilut
ad
well
eight
replic
six
day
infect
tissu
cultur
infect
dose
tcid
calcul
base
reedmuench
method
bvdvinfect
cell
homogen
lysi
buffer
beyotim
nanj
china
centrifug
rpm
min
supernat
incub
bead
chromotek
germani
h
bead
wash
pb
three
time
follow
resuspens
sd
sampl
buffer
boil
min
immunoprecipit
protein
analyz
western
blot
use
mous
antigfp
monoclon
antibodi
tiangen
beij
china
mous
polyclon
antibodi
result
base
least
three
independ
experi
statist
signific
determin
use
student
ttest
two
group
compar
oneway
analysi
varianc
anova
two
group
compar
control
group
p
valu
consid
statist
signific
solubl
recombin
protein
express
e
coli
transetta
cell
transform
vector
induct
mm
iptg
h
data
shown
recombin
protein
purifi
use
ninta
chromatographi
column
subsequ
gel
filtrat
column
sdspage
identif
result
show
molecular
weight
recombin
protein
approxim
kda
fig
express
purifi
nhi
recombin
protein
confirm
western
blot
use
antihi
monoclon
antibodi
result
observ
target
protein
band
kda
fig
purifi
recombin
protein
use
immun
screen
specificnanobodi
coat
antigen
immun
antibodi
serum
sampl
alashan
bactrian
camel
determin
ielisa
result
indic
antiserum
titer
increas
last
immun
compar
immun
fig
phage
display
vhh
librari
consist
approxim
individu
coloni
built
pbmc
immun
camel
posit
rate
analysi
coloni
pcr
reveal
coloni
contain
correct
insert
correspond
size
vhh
gene
next
randomli
select
clone
sequenc
analyz
clone
determin
contain
distinct
vhh
sequenc
suggest
divers
antibodi
librari
good
high
qualiti
screen
nanobodi
biopan
conduct
immobil
recombin
protein
vhh
recombin
phage
well
enrich
three
round
pan
tabl
clone
randomli
select
third
round
screen
ielisa
detect
ielisa
result
reveal
clone
posit
data
shown
next
coloni
sequenc
eight
differ
nanobodi
eventu
screen
base
amino
acid
sequenc
classif
antibodi
hypervari
region
name
deduc
amino
acid
sequenc
align
human
vh
sequenc
number
cdr
follow
method
describ
kabat
et
al
kabat
wu
data
fig
show
except
seven
nanobodi
typic
hydrophil
amino
h
duan
et
al
veterinari
microbiolog
acid
substitut
region
interestingli
also
display
notabl
reactiv
addit
ielisa
result
indic
eight
nanobodi
could
specif
bind
recombin
protein
crossreact
recombin
protein
fig
prrsv
recombin
protein
express
purifi
use
vector
method
use
bvdv
protein
also
contain
exclud
possibl
nanobodi
might
recogn
region
nanobodi
display
highest
affin
fig
base
result
three
nanobodi
select
subsequ
experiment
studi
neg
nanobodi
select
simultan
neg
control
gener
cell
line
stabli
express
nb
supernat
contain
pseudotyp
lentivirus
polybren
incub
mdbk
cell
screen
use
puromycin
h
transduct
surviv
cell
imag
use
fluoresc
microscop
name
egfp
egfp
egfp
respect
fig
cell
line
valid
western
blot
antigfp
antibodi
western
blot
result
indic
band
interest
detect
egfp
egfp
egfp
cell
line
kda
wildtyp
mdbk
cell
fig
confirm
mdbk
cell
line
stabli
express
nb
success
establish
next
determin
whether
intracellular
express
nanobodi
cytotox
cell
prolifer
assay
use
recombin
mdbknb
egfp
cell
line
wildtyp
mdbk
cell
perform
growth
curv
plot
time
result
show
stabl
express
intracellular
nanobodi
mdbknb
egfp
cell
line
cytotox
remark
differ
observ
recombin
wildtyp
cell
fig
sinc
preexperiment
result
impli
egfp
cell
line
antivir
activ
egfp
cell
line
show
weaker
antivir
activ
egfp
cell
round
round
fig
amino
acid
sequenc
align
nanobodi
human
vh
number
cdr
accord
previous
describ
method
kabat
et
al
hallmark
residu
posit
highlight
red
box
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
h
duan
et
al
veterinari
microbiolog
line
strong
antivir
effect
fig
egfp
cell
line
util
eventu
explor
antivir
effect
nanobodi
evalu
effect
intracellular
express
bvdv
infect
mdbk
egfp
egfp
cell
infect
moi
bvdv
cell
supernat
harvest
h
postinfect
hpi
rtqpcr
western
blot
perform
detect
mrna
protein
express
wherea
tcid
assay
appli
detect
supernat
viru
titer
rtqpcr
result
show
bvdv
mrna
protein
express
almost
undetect
h
bvdv
infect
egfp
cell
fig
b
number
bvdv
rna
copi
supernat
cell
also
decreas
significantli
fig
howev
mrna
protein
level
number
viru
copi
egfp
cell
control
group
significantli
differ
mdbk
cell
fig
furthermor
evalu
progeni
viru
titer
supernat
reveal
similar
result
viru
titer
differ
time
point
bvdv
infect
egfp
cell
fig
result
impli
intracellular
express
mdbk
cell
almost
complet
interfer
replic
moi
bvdv
known
rdrp
play
critic
role
bvdv
rna
synthesi
determin
effect
bvdv
replic
earli
stage
infect
rtqpcr
perform
within
h
inocul
result
show
signific
effect
bvdv
replic
earli
stage
infect
except
hpi
impli
mainli
exert
antivir
effect
late
stage
bvdv
infect
hpi
etc
earli
stage
infect
hpi
fig
verifi
effect
intrabodi
viral
replic
mdbknb
egfp
cell
infect
bvdv
moi
bvdvinduc
cpe
monitor
hpi
result
indic
bvdvinfect
mdbk
egfp
cell
show
signific
cpe
wherea
egfp
cell
obviou
fig
addit
cell
supernat
harvest
assess
protein
express
viral
titer
respect
western
blot
result
show
could
markedli
abrog
protein
express
differ
moi
fig
similarli
titrat
assay
result
suggest
could
significantli
prohibit
bvdv
replic
hpi
result
approxim
decreas
viral
titer
moi
respect
compar
mdbk
egfp
cell
fig
result
suggest
intrabodi
obvious
inhibit
bvdv
replic
differ
moi
evalu
antivir
capac
intrabodi
aforement
three
cell
line
infect
bvdv
moi
cell
viabil
evalu
hpi
use
assay
result
indic
intrabodi
promot
cell
surviv
three
moi
compar
mdbk
egfp
cell
fig
confirm
antibvdv
effect
intrabodi
confirm
interact
intracellularlyexpress
bvdvencod
bvdvinfect
cell
coimmunoprecipit
coip
assay
perform
lysat
bvdvinfect
mdbk
cell
line
stabli
express
nanobodi
egfp
egfp
cell
line
infect
moi
bvdv
cell
collect
hpi
coip
assay
result
reveal
could
interact
bvdvencod
bvdvinfect
cell
fig
result
suggest
intracellularlyexpress
might
recogn
function
epitop
inhibit
replic
viral
gene
therebi
inhibit
replic
bvdv
mdbk
cell
sinc
advent
hybridoma
technolog
monoclon
antibodi
wide
use
scientif
research
medic
diagnosi
treatment
liu
howev
despit
huge
potenti
develop
monoclon
antibodi
still
appar
limit
complex
structur
larg
molecular
weight
high
develop
product
cost
limit
applic
relat
field
develop
genet
engin
technolog
emerg
nanobodi
greatli
improv
antibodi
perform
uniqu
advantag
small
size
kda
high
specif
affin
recognit
specif
antigen
epitop
dmitriev
et
al
hassanzadehghassabeh
et
al
addit
accord
previou
report
nanobodi
solubl
due
typic
hydrophil
amino
acid
substitut
vu
et
al
thu
specul
substitut
hydrophil
amino
acid
hydrophob
amino
acid
studi
might
increas
hydrophil
nanobodi
fig
intrabodi
repres
import
class
therapeut
drug
potenti
use
microbi
diseas
therapi
interrupt
earli
late
event
viral
life
cycl
marasco
rondon
marasco
recent
studi
shown
sever
camel
singl
domain
intrabodi
target
rev
protein
ifv
nucleoprotein
hcv
envelop
protein
could
exert
antivir
activ
ashour
et
al
boon
et
al
serruy
et
al
indic
intracellularlyexpress
nb
effect
protect
host
viral
infect
bvd
great
concern
worldwid
detect
bind
eight
uniqu
nanobodi
use
ielisa
protein
use
control
b
titrat
bind
eight
screen
nanobodi
protein
ielisa
use
neg
antibodi
control
protein
coat
antigen
differ
dilut
nanobodi
ad
etag
primari
antibodi
h
duan
et
al
veterinari
microbiolog
bovin
industri
due
complex
genet
variabl
lack
effect
therapeut
drug
use
date
curti
jaeger
whether
intracellularlyexpress
nanobodi
exert
antivir
effect
bvdv
infect
whether
use
bvd
treatment
clear
thu
necessari
determin
effect
intracellularlyexpress
nanobodi
bvdv
infect
investig
effect
mdbk
cell
line
construct
stabli
express
intracellular
nb
shown
possess
rdrp
activ
play
pivot
role
transcript
replic
bvdv
genom
choi
et
al
therefor
nanobodi
screen
use
phage
display
studi
explor
antibvdv
effect
facilit
studi
stabl
cell
line
gener
first
packag
lentiviru
transduc
mdbk
cell
avoid
problem
associ
individu
transfect
also
result
stabl
effici
express
nb
fusion
protein
clarifi
nanobodi
success
deliv
cell
ctermin
egfp
fuse
nb
via
igahing
linker
act
marker
facilit
coip
detect
fig
report
fluoresc
proteinnanobodi
fusion
protein
capsid
protein
recogn
dynam
trace
morphogenesi
live
cell
novel
fluoresc
biosensor
provid
robust
tool
cellbas
hiv
research
helma
et
al
suggest
nanobodi
identifi
might
also
potenti
act
tool
direct
dynam
visual
bvdvinfect
live
cell
result
subsequ
viru
infect
experi
show
novel
nanobodi
name
specif
target
bvdv
significantli
abolish
viral
replic
fig
demonstr
intracellularlyexpress
nanobodi
suppress
bvdv
infect
vitro
studi
three
nb
high
affin
select
explor
antibvdv
activ
unexpectedli
even
though
three
nb
show
similar
vitro
affin
degre
inhibit
viral
replic
complet
differ
antivir
activ
show
weaker
antivir
activ
wherea
exhibit
strong
antivir
effect
fig
specul
differ
nb
might
bind
differ
epitop
could
bind
key
epitop
inhibit
rdrp
activ
thu
exert
strong
antivir
effect
protein
mainli
distribut
cytoplasm
bvdvinfect
cell
replic
transcript
viral
gene
also
primarili
occur
cytoplasm
impli
nb
might
exert
antivir
activ
mainli
target
protein
cytoplasm
surprisingli
ifa
western
blot
result
clearli
indic
nb
mainli
distribut
nucleu
small
portion
identifi
cytoplasm
fig
view
inconsist
result
inconsist
subcellular
local
protein
nb
antivir
molecular
mechan
nb
need
research
current
work
rna
virus
genom
high
variabl
western
blot
b
use
polyclon
antibodi
antibodi
extracellular
bvdv
rna
analyz
c
viru
titer
cultur
supernat
measur
base
tcid
valu
mdbk
egfp
egfp
cell
infect
moi
bvdv
h
cell
collect
rtqpcr
e
data
shown
mean
sd
repres
three
independ
experi
p
valu
calcul
use
anova
signific
differ
compar
control
valu
denot
p
bvdv
product
analyz
base
tcid
valu
b
protein
level
measur
western
blot
control
c
cell
viabil
assess
use
method
hpi
interact
intracellularli
express
bvdvencod
mdbk
cell
infect
bvdv
egfp
egfp
cell
line
infect
moi
bvdv
cell
collect
hpi
immunoprecipit
protein
analyz
western
blot
use
mous
antigfp
monoclon
antibodi
mous
polyclon
antibodi
e
data
shown
mean
sd
repres
three
independ
experi
p
valu
calcul
use
anova
signific
differ
compar
control
valu
denot
p
h
duan
et
al
veterinari
microbiolog
neutral
epitop
region
viral
structur
protein
tend
high
variabl
due
immun
pressur
wherea
function
region
nonstructur
protein
locat
cytoplasm
rel
conserv
chand
et
al
protein
highli
conserv
genu
pestiviru
uniqu
function
nonstructur
protein
play
import
role
viral
replic
rdrp
activ
choi
et
al
provid
ideal
target
develop
antibvdv
drug
due
advantag
unmatch
tradit
antibodi
nb
broad
valu
clinic
applic
pardon
et
al
siontor
howev
biggest
problem
associ
intracellular
antibodi
deliveri
relat
express
gene
cell
sever
possibl
strategi
develop
overcom
problem
nanobodi
gene
deliveri
cell
via
intrabodi
gene
therapi
deliveri
strategi
southwel
et
al
transactiv
transduct
tat
peptid
fusion
promot
protein
entri
cell
report
provid
use
refer
research
applic
intracellular
nanobodi
bvdv
repres
ongo
work
laboratori
conclus
bvdv
nanobodi
isol
camel
vhh
librari
phage
display
technolog
one
nanobodi
shown
significantli
suppress
bvdv
replic
interact
bvdvencod
result
suggest
intracellularli
express
potenti
develop
antibvdv
agent
none
